Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

Europe - AMS:CTAC - NL0000345577 - Common Stock

3.34 EUR
+0.01 (+0.3%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

5

Overall CTAC gets a fundamental rating of 5 out of 10. We evaluated CTAC against 71 industry peers in the IT Services industry. CTAC has only an average score on both its financial health and profitability. CTAC is valued quite cheap, while showing a decent growth score. This is a good combination! CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CTAC was profitable.
In the past year CTAC had a positive cash flow from operations.
Each year in the past 5 years CTAC has been profitable.
In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

The Return On Assets of CTAC (5.74%) is better than 66.20% of its industry peers.
Looking at the Return On Equity, with a value of 13.36%, CTAC is in line with its industry, outperforming 56.34% of the companies in the same industry.
CTAC has a Return On Invested Capital (7.06%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CTAC is below the industry average of 11.13%.
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROIC 7.06%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.28%, CTAC is in line with its industry, outperforming 49.30% of the companies in the same industry.
In the last couple of years the Profit Margin of CTAC has grown nicely.
With a Operating Margin value of 4.54%, CTAC perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
CTAC's Operating Margin has improved in the last couple of years.
CTAC has a worse Gross Margin (54.86%) than 61.97% of its industry peers.
CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

CTAC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CTAC has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTAC has more shares outstanding
CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CTAC has an Altman-Z score of 3.02. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
CTAC's Altman-Z score of 3.02 is fine compared to the rest of the industry. CTAC outperforms 63.38% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that CTAC is not too dependend on debt financing.
CTAC has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: CTAC outperforms 56.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC0.57
WACC12.31%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

CTAC has a Current Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.00, CTAC is doing worse than 71.83% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that CTAC should not have too much problems paying its short term obligations.
CTAC has a Quick ratio of 1.00. This is in the lower half of the industry: CTAC underperforms 69.01% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 351.71%, which is quite impressive.
CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.20% yearly.
CTAC shows a small growth in Revenue. In the last year, the Revenue has grown by 0.81%.
Measured over the past years, CTAC shows a quite strong growth in Revenue. The Revenue has been growing by 8.74% on average per year.
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%

3.2 Future

CTAC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.55% yearly.
CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.96%
Revenue Next 5Y7.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.52, which indicates a very decent valuation of CTAC.
Based on the Price/Earnings ratio, CTAC is valued cheaper than 85.92% of the companies in the same industry.
CTAC is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.80, the valuation of CTAC can be described as very cheap.
90.14% of the companies in the same industry are more expensive than CTAC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.73. CTAC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.52
Fwd PE 7.8
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

80.28% of the companies in the same industry are more expensive than CTAC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.78
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTAC's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)0.25
PEG (5Y)0.48
EPS Next 2Y30.93%
EPS Next 3Y21.55%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.30%, CTAC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.54, CTAC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, CTAC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.3%

5.2 History

The dividend of CTAC is nicely growing with an annual growth rate of 17.13%!
Dividend Growth(5Y)17.13%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

CTAC pays out 37.91% of its income as dividend. This is a sustainable payout ratio.
CTAC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.91%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (9/12/2025, 7:00:00 PM)

3.34

+0.01 (+0.3%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.08%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap47.26M
Analysts85
Price Target3.83 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.3%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP37.91%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.52
Fwd PE 7.8
P/S 0.38
P/FCF N/A
P/OCF 20.14
P/B 1.54
P/tB 11.07
EV/EBITDA 4.78
EPS(TTM)0.29
EY8.68%
EPS(NY)0.43
Fwd EY12.83%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.17
OCFY4.97%
SpS8.85
BVpS2.17
TBVpS0.3
PEG (NY)0.25
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROCE 15.2%
ROIC 7.06%
ROICexc 7.47%
ROICexgc 21.3%
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexcg growth 3Y-10.84%
ROICexcg growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score5
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 1.02
Cap/Depr 69.4%
Cap/Sales 2.97%
Interest Coverage 14.65
Cash Conversion 21.25%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.02
F-Score5
WACC12.31%
ROIC/WACC0.57
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.96%
Revenue Next 5Y7.12%
EBIT growth 1Y24.33%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year66.67%
EBIT Next 3Y20.12%
EBIT Next 5YN/A
FCF growth 1Y-114.47%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-79.51%
OCF growth 3Y2.52%
OCF growth 5Y4.91%